scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.
View Top Employees from scPharmaceuticalsWebsite | http://scpharmaceuticals.com/ |
Ticker | SCPH |
Revenue | $8.8 million |
Funding | $107.6 million |
Employees | 125 (104 on RocketReach) |
Founded | 2014 |
Address | 25 Mall Road Suite 203, Burlington, Massachusetts 01803, US |
Phone | (617) 517-0730 |
Technologies |
JavaScript,
HTML,
PHP
+21 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Health Care, Improving Diuresis in Heart Failure, Medical, Drug Delivery, Next Generation OPAT, Healthcare, Pharmaceutical, Medical Countermeasure Solutions |
Web Rank | 3 Million |
Keywords | Drug Development And Manufacturing, Biotechnology, Healthcare Treatment, Medical Innovation, Health And Wellness, Patient Care |
Competitors | Depomed, Inc., Esperion, Heron Therapeutics, Inc., Innocoll Biotherapeutics, Lipocine Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular scPharmaceuticals employee's phone or email?
The scPharmaceuticals annual revenue was $8.8 million in 2024.
John Mohr is the Senior Vice President, Clinical Development and Medical Affairs of scPharmaceuticals.
104 people are employed at scPharmaceuticals.
scPharmaceuticals is based in Burlington, Massachusetts.
The NAICS codes for scPharmaceuticals are [32, 32541, 325, 3254].
The SIC codes for scPharmaceuticals are [283, 28].